Skip to content

Clinical trials

Drug Resistant Epilepsy trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug Resistant Epilepsy Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20183
20191
20202
20231
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Active, not recruiting2
Completed2
Enrolling by invitation2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biohaven Therapeutics Ltd.3
UCB Biopharma SRL2
Cerebral Therapeutics LLC1
Duke University1
ES Therapeutics Australia Pty Ltd1
Genovate-NaviFUS (Australia) Pty Ltd.1
LivaNova1
UCB Biopharma S.P.R.L.1
iQure Australia Pty Ltd1
iVEAcare1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug Resistant Epilepsy13
Seizures8
Epilepsy7
Epilepsies, Partial2
Epilepsy, Absence1
Epilepsy, Generalized1
Epilepsy, Temporal Lobe1
Myoclonic Epilepsy, Juvenile1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.